Atlas Trials

Human Immunodeficiency Virus Type 1

13 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Human Immunodeficiency Virus Type 1

RecordFirmDate
MK-8510 Monotherapy for the Treatment of Anti-retroviral naïve Human Immunodeficiency Virus Type 1 (HIV-1) Infected Participants (MK-8510-002) (NCT05700734)Merck Sharp & Dohme LLC2023-04-17
A Study of MGD020 Alone or Combined With MGD014 in Persons With HIV-1 on Antiretroviral Therapy (NCT05261191)MacroGenics2022-09-26
Oral ISL QM as PrEP in Cisgender Women at High Risk for HIV-1 Infection (MK-8591-022) (NCT04644029)Merck Sharp & Dohme LLC2021-02-24
A Study to Evaluate the Pharmacokinetic Effects of Different Storage Conditions for a Long-Acting Nanosuspension of Rilpivirine on Pharmacokinetics (NCT02547870)Janssen Infectious Diseases BVBA2015-08-14
A Roll-over Study With Rilpivirine for Human Immunodeficiency Virus Type 1 (HIV-1) Infected Participants Who Participated in Rilpivirine Pediatric Studies (NCT02494986)Janssen Sciences Ireland UC2015-07-06
Study to Evaluate Efficacy and Safety of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Regimen Versus Boosted Protease Inhibitor (bPI) Along With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Regimen in Virologically-Suppressed, HIV-1 Infected Participants (NCT02269917)Janssen R&D Ireland2015-03-01
A Study to Assess the Safety and Effectiveness of Darunavir for Treating Human Immunodeficiency Virus-Type I (HIV-1) Infection in Filipino Patients (NCT01726348)Janssen Pharmaceutica2014-01-01
A Study to Determine the Antiviral Activity of TMC310911 When Administered With Ritonavir in Treatment-Naive Human Immunodeficiency Virus - Type 1 (HIV-1) Infected Patients (NCT00838162)Tibotec Pharmaceuticals, Ireland2009-06-01
Maraviroc Compassionate Use (NCT00719823)ViiV Healthcare2008-08-01
TMC278-TiDP6-C209: A Clinical Trial in Treatment Naive HIV-1 Patients Comparing TMC278 to Efavirenz in Combination With Tenofovir + Emtricitabine. (NCT00540449)Tibotec Pharmaceuticals, Ireland2008-05-01
A Study to Compare Effectiveness and Safety of Darunavir/Ritonavir (DRV/Rtv) 800mg/100mg Once Daily Versus DRV/Rtv 600mg/100mg Twice Daily in Early Treatment-Experienced HIV-1 Infected Patients (ODIN) (NCT00524368)Tibotec Pharmaceuticals, Ireland2007-10-01
A Study With TMC125 in Human Immunodeficiency Virus (HIV) Type 1 Infected Patients, Who Were Treated With TMC125 Arm in a Sponsor-Selected TMC125 Study (NCT00128830)Tibotec Pharmaceuticals, Ireland2005-06-01
A Study of TMC278 in Human Immunodeficiency Virus Type 1 Infected Patients, Who Are Not Treated With Antiretroviral Medicines (NCT00110305)Tibotec Pharmaceuticals, Ireland2005-06-01

Track Human Immunodeficiency Virus Type 1 automatically

Every clearance here is in the API, with alerts when new ones post.